Biologic Solutions for Chronic Wounds in Little Rock, AR

What I’d check before adding biologic solutions chronic wounds here

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 13.1% of adults in Little Rock have diagnosed diabetes — 1.1 points above the U.S. 12% figure. 11.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick biologic solutions chronic wounds against that mix.

Cash PRP and Medicare CTPs in the same hallway

• CDC PLACES (2023, crude) estimates 13.1% of adults in Little Rock have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Adult obesity in Little Rock is 40.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JH review. Product is the last step, not the first.
• Medicare wound-care biologics in Arkansas are paid under Novitas Solutions (JH). CTP and skin-substitute LCDs are MAC-specific — a protocol that billed cleanly in another jurisdiction can stall here if documentation does not match JH coverage articles.
• JH (Novitas Solutions) is the contractor that will review CTP units, application frequency, and wound measurements for Arkansas Part B claims. Practices that skip MAC education typically see denials before they see outcomes.

Payer geography for Little Rock, AR

JH reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Little Rock is 13.1% or not. PLACES is planning data. The LCD is the claim.

Staff, tickets, photos — in that order